-
公开(公告)号:US20070197522A1
公开(公告)日:2007-08-23
申请号:US10591108
申请日:2005-02-25
申请人: Paul Edwards , Achim Feurer , Silvia Cerezo-Galves , Victor Matassa , Sonja Nordhoff , Claudia Rosenbaum , Stephan Bulat
发明人: Paul Edwards , Achim Feurer , Silvia Cerezo-Galves , Victor Matassa , Sonja Nordhoff , Claudia Rosenbaum , Stephan Bulat
IPC分类号: A61K31/135 , A61K31/535 , C07C211/08 , C07D207/09 , C07D295/03
CPC分类号: C07D213/40 , C07C237/20 , C07C237/42 , C07C311/35 , C07C311/46 , C07C323/41 , C07C2602/08 , C07C2602/10 , C07D205/04 , C07D207/10 , C07D207/14 , C07D213/42 , C07D213/75 , C07D217/14 , C07D231/12 , C07D233/54 , C07D235/14 , C07D241/12 , C07D241/18 , C07D249/08 , C07D261/08 , C07D271/06 , C07D295/125 , C07D295/13 , C07D295/135 , C07D307/79 , C07D311/76 , C07D319/18 , C07D471/04
摘要: The invention relates to compounds of formula (I) Z-C(R1R2)—C(R3NH2)—C(R4R5)—X—N(R6R7) (I), wherein Z, R1-7 and X have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV inhibitors. The invention also relates to the preparation of such compounds as well as the production and use thereof as medicament.
摘要翻译: 本发明涉及式(I)化合物<?in-line-formula description =“In-line Formulas”end =“lead”→> ZC(R 1> 2 u> )(C(R 3)NH 2)-C(R 4,R 5) - XN(R 4) (I),<?在线公式描述=“在线公式”end =“tail”?>其中Z,R < SUP> 1-7和X具有在说明书和权利要求书中引用的含义。 所述化合物可用作DPP-IV抑制剂。 本发明还涉及这种化合物的制备以及其作为药物的生产和使用。
-
公开(公告)号:US20080064728A1
公开(公告)日:2008-03-13
申请号:US11572664
申请日:2005-08-03
IPC分类号: A61K31/4427 , A61K31/4245 , A61P1/00 , A61P13/12 , A61P15/08 , A61P19/10 , A61P25/00 , A61P3/04 , A61P3/10 , A61P31/18 , A61P35/00 , A61P37/00 , A61P9/10 , C07D213/02 , C07D271/06
CPC分类号: C07D413/04 , C07D271/06
摘要: The invention relates to compounds of formula Z-C(R1R2)—C(R3NH2)—C(R4R5)-A (I) wherein Z, R —R and A have the meaning as cited in the description and the claims as examplified by the compound (II) said compounds are useful as DPP-IV inhibitors. The invention also relates to the preparation of such compounds as well as the production and use thereof as medicament.
摘要翻译: 本发明涉及式<β的化合物在线式描述=“In-line Formulas”end =“lead”→> ZC(R 1→R 2) -C(R 3)NH 2)-C(R 4,R 5) - (I) 其中Z,R-R和A具有由化合物(II)例示的说明书和权利要求中引用的含义,所述化合物(II)表示化合物 作为DPP-IV抑制剂是有用的。 本发明还涉及这种化合物的制备以及其作为药物的生产和使用。
-